December 20, 2021
Life Sciences
  • Moderna said preliminary data shows that its COVID-19 booster provides protection against omicron, but that a double dose of the booster shot provided a much greater increase in those levels. Its currently FDA-approved 50ug booster was found to increase neutralizing antibody levels against omicron 37-fold compared to pre-boost levels. Meanwhile, it found that a 100ug booster dose gave an 83-fold increase in neutralizing antibody levels. The drug company will still be developing a new shot specific to the omicron variant. (Articles here, herehere, and here)